BlueCrest Capital Management Ltd XBI Holdings History
BlueCrest Capital Management Ltd's SPDR Biotech ETF Holding Summary
As of 2025-03-31, BlueCrest Capital Management Ltd held - shares of SPDR Biotech ETF(XBI), totaling N/A. This investment constitutes 0% of their stock portfolio, and BlueCrest Capital Management Ltd now holds 0% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2024Q4. And since then BlueCrest Capital Management Ltd has made 1 purchases of XBI, at an average price of $96.87, for a total of 1.53 Mil shares. In addition, there have been 1 sales at an average price of $89.38 for 1.53 Mil shares. Based on historical transaction data and XBI's current price of $86.73, BlueCrest Capital Management Ltd's estimated gain on his XBI holdings is $-11.48 Mil, reflecting a -7.73% gain to date.
BlueCrest Capital Management Ltd XBI ($86.73) Holding Chart
BlueCrest Capital Management Ltd XBI ($86.73) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
